Imaging tumor response during radiation for sarcoma
Part of Cancer clinical trials.
This trial will see if special MRI scans taken during radiation therapy can help predict how well the tumor responds, potentially guiding future treatment. You will receive standard radiation for sarcoma and have a few extra MRI scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with soft tissue sarcoma (a type of cancer in muscles, fat, or other soft tissues).
- You are scheduled to receive radiation therapy (50 Gy over 5 weeks) before surgery to remove the tumor.
- You are 18 years of age or older.
- You are physically able to carry out daily activities with minimal help (ECOG performance status 0-2).
- You are not diagnosed with Ewing's sarcoma or rhabdomyosarcoma (specific sarcoma subtypes).
- You can receive MRI contrast (gadolinium) and undergo multiple MRI scans, including three extra scans during radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses repeated MRI scans during radiation treatment to see how tumors change. It may help doctors adjust treatment and improve outcomes for many types of cancer.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
This study tests whether MRI scans can replace CT scans to map bone tumors and plan surgery. If successful, it may allow some patients to avoid CT radiation.
This trial compares CT scans to chest X-rays to monitor for lung cancer spread after surgery to remove soft tissue sarcoma. If you are at high risk of the sarcoma returning in your lungs, this study helps see which imaging method works better.
This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.
This trial tests a personalized (“adaptive”) radiation plan before surgery for high-grade soft-tissue sarcoma that can be removed. It may help shrink the tumor and improve how well surgery can treat the cancer.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.